Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
Yahoo
Monday, May 4, 2009 - 8:09am
tags:
AstraZeneca, NDA, esomeprazole
Invitrogen Develops New Technology to Promote Safer Stem Cell Therapies
Yahoo
Monday, May 4, 2009 - 7:37am
tags:
Invitrogen, stem cells
Medarex, a Bright Spot in Biotech
Businessweek
Monday, May 4, 2009 - 7:36am
tags:
Medarex, biotech, pipelines
An Alzheimer's Expert Discusses the Next Generation of Drugs
Seeking Alpha
Monday, May 4, 2009 - 7:34am
tags:
Alzheimer's disease, Elan, Eli Lilly, Pfizer, Wyeth
Solvay bidders, start your engines
Fierce Pharma
Sunday, May 3, 2009 - 9:37am
tags:
Solvay, M&A, Novartis, AstraZeneca, Bayer, Takeda, Abbott Laboratories
A Break for Pharma? Grassley May Leave Finance Panel
WSJ Online
Sunday, May 3, 2009 - 9:36am
tags:
Charles Grassley, pharma industry
Opinion: Off-label drug use: Derms weigh in on role of pharmaceutical reps
Modern Medicine/Dermatology Times
Sunday, May 3, 2009 - 9:33am
tags:
drug reps, off-label, dermatology
EXACT Sciences Shows Strong Breakout
Seeking Alpha
Sunday, May 3, 2009 - 9:28am
tags:
EXACT Sciences
More on China Biotech Deals: M&A Numbers Misleading
Seeking Alpha
Sunday, May 3, 2009 - 9:27am
tags:
China, biotech, M&A, Alnylam, ChinaBio
Sinovac on Track to Produce H1N1 Vaccine
Seeking Alpha
Sunday, May 3, 2009 - 9:25am
tags:
Sinovac, vaccines, Flu, swine flu, H1N1
InterMune shares fall on 1st-quarter loss; analysts look ahead to developing treatments
Yahoo/AP
Sunday, May 3, 2009 - 9:25am
tags:
InterMune, earnings
Dendreon Investors, Be Patient
TheStreet.com
Sunday, May 3, 2009 - 9:24am
tags:
Dendreon, prostate cancer, Provenge
BioMarin shares rise; analysts keep positive view
Yahoo/AP
Sunday, May 3, 2009 - 9:23am
tags:
Biomarin
[video] Cramer: Impossible to Own Drugs Here
TheStreet.com
Sunday, May 3, 2009 - 9:21am
tags:
Pfizer, Merck, Eli Lilly, Bristol-Myers Squibb, St. Jude Medical, Schering Plough
Amylin and Lilly partner to develop new pen device for diabetes therapy
Pharmaceutical Business Review
Friday, May 1, 2009 - 10:44am
tags:
diabetes, Amylin, Eli Lilly, partnerships, exanitide
Gilead to Benefit from Tamiflu Orders
Yahoo/Zacks.com
Friday, May 1, 2009 - 10:43am
tags:
Gilead Sciences, Flu, swine flu, Tamiflu, Roche
Allergan reports lower first-quarter profit
Marketwatch
Friday, May 1, 2009 - 10:42am
tags:
Allergan, earnings
AstraZeneca in talks about swine flu vaccine
Hays Pharma, UK
Friday, May 1, 2009 - 9:01am
tags:
AstraZeneca, swine flu, vaccines
Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
Pharma Live
Friday, May 1, 2009 - 8:59am
tags:
Watson Pharmaceuticals, earnings
Sepracor Building a Base
Yahoo/Zacks.com
Friday, May 1, 2009 - 7:26am
tags:
Sepracor

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.